MRNA Therapeutics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

MRNA Therapeutics Market: By Type (Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs), By Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases11.2.5. Others), By End User (Hospitals & Clinics, Research Organizations, Others), and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

1. Executive Summary
2. Global MRNA Therapeutics Market Introduction
2.1. Global MRNA Therapeutics Market – Taxonomy
2.2. Global MRNA Therapeutics Market –Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global MRNA Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Pipeline Analysis
3.6. Market Product Analysis
3.7. Disease Landscape
3.8. Product Landscape
3.9. Global MRNA Therapeutics Market Dynamic Factors – Impact Analysis
3.10. Global MRNA Therapeutics Market – Competition Landscape
4. Global MRNA Therapeutics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global MRNA Therapeutics Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Prophylactic Vaccines
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Therapeutic Vaccines
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Therapeutic Drugs
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global MRNA Therapeutics Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Rare Genetic Diseases
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Oncology
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Respiratory Diseases
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Diseases
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global MRNA Therapeutics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals & Clinics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Organizations
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global MRNA Therapeutics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global MRNA Therapeutics Market – Opportunity Analysis Index, By Type, Application, End User, and Region, 2022-2028
9. North America MRNA Therapeutics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prophylactic Vaccines
9.1.2. Therapeutic Vaccines
9.1.3. Therapeutic Drugs
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Rare Genetic Diseases
9.2.2. Oncology
9.2.3. Respiratory Diseases
9.2.4. Infectious Diseases
9.2.5. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals & Clinics
9.3.2. Research Organizations
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
9.6. North America MRNA Therapeutics Market Dynamics – Trends
10. Europe MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prophylactic Vaccines
10.1.2. Therapeutic Vaccines
10.1.3. Therapeutic Drugs
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Rare Genetic Diseases
10.2.2. Oncology
10.2.3. Respiratory Diseases
10.2.4. Infectious Diseases
10.2.5. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals & Clinics
10.3.2. Research Organizations
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
10.6. Europe MRNA Therapeutics Market Dynamics – Trends
11. Asia-Pacific MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prophylactic Vaccines
11.1.2. Therapeutic Vaccines
11.1.3. Therapeutic Drugs
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Rare Genetic Diseases
11.2.2. Oncology
11.2.3. Respiratory Diseases
11.2.4. Infectious Diseases
11.2.5. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals & Clinics
11.3.2. Research Organizations
11.3.3. Others
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
11.6. Asia-Pacific MRNA Therapeutics Market Dynamics – Trends
12. Latin America MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prophylactic Vaccines
12.1.2. Therapeutic Vaccines
12.1.3. Therapeutic Drugs
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Rare Genetic Diseases
12.2.2. Oncology
12.2.3. Respiratory Diseases
12.2.4. Infectious Diseases
12.2.5. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals & Clinics
12.3.2. Research Organizations
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
12.6. Latin America MRNA Therapeutics Market Dynamics – Trends
13. Middle East and Africa MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Prophylactic Vaccines
13.1.2. Therapeutic Vaccines
13.1.3. Therapeutic Drugs
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Rare Genetic Diseases
13.2.2. Oncology
13.2.3. Respiratory Diseases
13.2.4. Infectious Diseases
13.2.5. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals & Clinics
13.3.2. Research Organizations
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
13.6. MEA MRNA Therapeutics Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Moderna, Inc.
14.2.2. BioNTech SE
14.2.3. CureVac N.V.
14.2.4. Arcturus Therapeutics
14.2.5. Translate Bio, Inc.
14.2.6. GSK plc.
14.2.7. Argos Therapeutics Inc.
14.2.8. Sangamo Therapeutics, Inc.
14.2.9. Pfizer Inc.
14.2.10. AstraZeneca plc.
14.2.11. Sanofi
14.2.12. CRISPR Therapeutics AG
15. Research Methodology
16. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

 

  • Moderna, Inc.
  •  BioNTech SE
  • CureVac N.V.
  •  Arcturus Therapeutics
  •  Translate Bio, Inc.
  •  GSK plc.
  •  Argos Therapeutics Inc.
  •  Sangamo Therapeutics, Inc.
  •  Pfizer Inc.
  • AstraZeneca plc.
  •  Sanofi
  •  CRISPR Therapeutics AG

Description

1. Executive Summary
2. Global MRNA Therapeutics Market Introduction
2.1. Global MRNA Therapeutics Market – Taxonomy
2.2. Global MRNA Therapeutics Market –Definitions
2.2.1. By Type
2.2.2. By Application
2.2.3. By End User
2.2.4. By Region
3. Global MRNA Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Pipeline Analysis
3.6. Market Product Analysis
3.7. Disease Landscape
3.8. Product Landscape
3.9. Global MRNA Therapeutics Market Dynamic Factors – Impact Analysis
3.10. Global MRNA Therapeutics Market – Competition Landscape
4. Global MRNA Therapeutics Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global MRNA Therapeutics Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Prophylactic Vaccines
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Therapeutic Vaccines
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Therapeutic Drugs
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global MRNA Therapeutics Market Forecast, By Application, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Rare Genetic Diseases
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Oncology
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Respiratory Diseases
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Infectious Diseases
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global MRNA Therapeutics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Hospitals & Clinics
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Research Organizations
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Others
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global MRNA Therapeutics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global MRNA Therapeutics Market – Opportunity Analysis Index, By Type, Application, End User, and Region, 2022-2028
9. North America MRNA Therapeutics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Prophylactic Vaccines
9.1.2. Therapeutic Vaccines
9.1.3. Therapeutic Drugs
9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Rare Genetic Diseases
9.2.2. Oncology
9.2.3. Respiratory Diseases
9.2.4. Infectious Diseases
9.2.5. Others
9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.3.1. Hospitals & Clinics
9.3.2. Research Organizations
9.3.3. Others
9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
9.6. North America MRNA Therapeutics Market Dynamics – Trends
10. Europe MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prophylactic Vaccines
10.1.2. Therapeutic Vaccines
10.1.3. Therapeutic Drugs
10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Rare Genetic Diseases
10.2.2. Oncology
10.2.3. Respiratory Diseases
10.2.4. Infectious Diseases
10.2.5. Others
10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Hospitals & Clinics
10.3.2. Research Organizations
10.3.3. Others
10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
10.6. Europe MRNA Therapeutics Market Dynamics – Trends
11. Asia-Pacific MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prophylactic Vaccines
11.1.2. Therapeutic Vaccines
11.1.3. Therapeutic Drugs
11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Rare Genetic Diseases
11.2.2. Oncology
11.2.3. Respiratory Diseases
11.2.4. Infectious Diseases
11.2.5. Others
11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Hospitals & Clinics
11.3.2. Research Organizations
11.3.3. Others
11.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
11.6. Asia-Pacific MRNA Therapeutics Market Dynamics – Trends
12. Latin America MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prophylactic Vaccines
12.1.2. Therapeutic Vaccines
12.1.3. Therapeutic Drugs
12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Rare Genetic Diseases
12.2.2. Oncology
12.2.3. Respiratory Diseases
12.2.4. Infectious Diseases
12.2.5. Others
12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Hospitals & Clinics
12.3.2. Research Organizations
12.3.3. Others
12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
12.6. Latin America MRNA Therapeutics Market Dynamics – Trends
13. Middle East and Africa MRNA Therapeutics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. By Type Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Prophylactic Vaccines
13.1.2. Therapeutic Vaccines
13.1.3. Therapeutic Drugs
13.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Rare Genetic Diseases
13.2.2. Oncology
13.2.3. Respiratory Diseases
13.2.4. Infectious Diseases
13.2.5. Others
13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Hospitals & Clinics
13.3.2. Research Organizations
13.3.3. Others
13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA MRNA Therapeutics Market – Opportunity Analysis Index, By  Type, Application, End User, and Country, 2022-2028
13.6. MEA MRNA Therapeutics Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Application& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Moderna, Inc.
14.2.2. BioNTech SE
14.2.3. CureVac N.V.
14.2.4. Arcturus Therapeutics
14.2.5. Translate Bio, Inc.
14.2.6. GSK plc.
14.2.7. Argos Therapeutics Inc.
14.2.8. Sangamo Therapeutics, Inc.
14.2.9. Pfizer Inc.
14.2.10. AstraZeneca plc.
14.2.11. Sanofi
14.2.12. CRISPR Therapeutics AG
15. Research Methodology
16. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX